 Connection
Petter Bjornstad to Prognosis
This is a "connection" page, showing publications Petter Bjornstad has written about Prognosis.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.930 |
|
|
|
-
Platnick C, Choi YJ, Narongkiatikhun P, Bekelman N, Rountree-Jablin C, Birznieks C, Sell E, Tommerdahl KL, de Boer I, Shah VN, Nadeau KJ, Sawyer A, Pyle L, Bjornstad P. Relationships among biological sex, body composition, and bone mineral density in young persons with and without diabetes. J Pediatr Endocrinol Metab. 2025 May 26; 38(5):476-487.
Score: 0.118
-
Saulnier PJ, Looker HC, Mauer M, Najafian B, Gand E, Ragot S, Nelson RG, Bjornstad P. Intraglomerular Dysfunction Predicts Kidney Failure in Type 2 Diabetes. Diabetes. 2021 10; 70(10):2344-2352.
Score: 0.091
-
van Raalte DH, Bjornstad P. Role of sodium-glucose cotransporter 2 inhibition to mitigate diabetic kidney disease risk in type 1 diabetes. Nephrol Dial Transplant. 2020 01 01; 35(Suppl 1):i24-i32.
Score: 0.082
-
Bjornstad P, Laffel L, Lynch J, El Ghormli L, Weinstock RS, Tollefsen SE, Nadeau KJ. Elevated Serum Uric Acid Is Associated With Greater Risk for Hypertension and Diabetic Kidney Diseases in Obese Adolescents With Type 2 Diabetes: An Observational Analysis From the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study. Diabetes Care. 2019 06; 42(6):1120-1128.
Score: 0.078
-
Bjornstad P, Wiromrat P, Johnson RJ, Sippl R, Cherney DZI, Wong R, Rewers MJ, Snell-Bergeon JK. Serum Uromodulin Predicts Less Coronary Artery Calcification and Diabetic Kidney Disease Over 12 Years in Adults With Type 1 Diabetes: The CACTI Study. Diabetes Care. 2019 02; 42(2):297-302.
Score: 0.076
-
Bjornstad P, Singh SK, Snell-Bergeon JK, Lovshin JA, Lytvyn Y, Lovblom LE, Rewers MJ, Boulet G, Lai V, Tse J, Cham L, Orszag A, Weisman A, Keenan HA, Brent MH, Paul N, Bril V, Perkins BA, Cherney DZI. The relationships between markers of tubular injury and intrarenal haemodynamic function in adults with and without type 1 diabetes: Results from the Canadian Study of Longevity in Type 1 Diabetes. Diabetes Obes Metab. 2019 03; 21(3):575-583.
Score: 0.076
-
Bjornstad P, Costacou T, Miller RG, Maahs DM, Rewers MJ, Orchard TJ, Snell-Bergeon JK. Predictors of early renal function decline in adults with Type 1 diabetes: the Coronary Artery Calcification in Type 1 Diabetes and the Pittsburgh Epidemiology of Diabetes Complications studies. Diabet Med. 2017 11; 34(11):1532-1540.
Score: 0.070
-
Bjornstad P, Maahs DM, Wadwa RP, Pyle L, Rewers M, Eckel RH, Snell-Bergeon JK. Plasma triglycerides predict incident albuminuria and progression of coronary artery calcification in adults with type 1 diabetes: the Coronary Artery Calcification in Type 1 Diabetes Study. J Clin Lipidol. 2014 Nov-Dec; 8(6):576-583.
Score: 0.057
-
Bjornstad P, Maahs DM, Rewers M, Johnson RJ, Snell-Bergeon JK. ABC goal achievement predicts microvascular but not macrovascular complications over 6-years in adults with type 1 diabetes: the Coronary Artery Calcification in Type 1 Diabetes Study. J Diabetes Complications. 2014 Nov-Dec; 28(6):762-6.
Score: 0.056
-
Moedt E, Ju W, Nair V, Bjornstad P, Kretzler M, Heerspink HJL. Novel protein biomarkers for risk stratification and personalized medicine. Nephrol Dial Transplant. 2026 Aug 25; 41(Supplement_2):ii50-ii58.
Score: 0.033
-
van Baar MJB, Bjornstad P, Touw DJ, Joles JA, Krebber MM, Cherney DZI, van Raalte DH, Muskiet MHA. Renal functional reserve predicts GFR response to empagliflozin in RENALIS and RACELINES clinical trials. Nephrol Dial Transplant. 2026 Jul 31; 41(8):1520-1528.
Score: 0.032
-
Liu JJ, Liu S, de Keizer J, Zheng H, Lee J, Javaugue V, Gurung RL, Ang K, Potier L, Nelson RG, Kestenbaum B, Bjornstad P, Lim SC, Hadjadj S, Saulnier PJ. Fasting urine osmolality and risk of kidney disease progression in patients with type 2 diabetes. Nephrol Dial Transplant. 2026 Jun 30; 41(7):1304-1312.
Score: 0.032
-
Heerspink HJL, van Raalte DH, Bjornstad P, Bunck MC, Wu P, Tunali I, Milicevic Z, Koeneman L. Rationale, design and baseline characteristics of the TRANSCEND-CKD trial of retatrutide in patients with chronic kidney disease. Nephrol Dial Transplant. 2026 May 29; 41(6):1058-1068.
Score: 0.032
-
Cherney DZI, Belmar N, Bjornstad P, Chacko MM, Gunnarsson TP, Hodgin JB, Kretzler M, Pruijm M, Schytz PA, Tuttle KR. Rationale, design and baseline characteristics of REMODEL, a mechanism-of-action trial with semaglutide in people with type 2 diabetes and chronic kidney disease. Nephrol Dial Transplant. 2025 Oct 30; 40(11):2182-2192.
Score: 0.031
-
Thomas P, Missikpode C, Martinez OG, Verma A, Zhao R, Claudel SE, Schmidt IM, van Raalte DH, Bjornstad P, Layden BT, Lash JP, Waikar SS, Srivastava A. Association of Pancreas Volume With Adverse Clinical Outcomes. J Am Heart Assoc. 2025 Nov 04; 14(21):e042348.
Score: 0.031
-
Lovshin JA, ?krtic M, Bjornstad P, Moineddin R, Daneman D, Dunger D, Reich HN, Mahmud F, Scholey J, Cherney DZI, Sochett E. Hyperfiltration, urinary albumin excretion, and ambulatory blood pressure in adolescents with Type 1 diabetes mellitus. Am J Physiol Renal Physiol. 2018 04 01; 314(4):F667-F674.
Score: 0.018
-
Kuwabara M, Niwa K, Hisatome I, Nakagawa T, Roncal-Jimenez CA, Andres-Hernando A, Bjornstad P, Jensen T, Sato Y, Milagres T, Garcia G, Ohno M, Lanaspa MA, Johnson RJ. Asymptomatic Hyperuricemia Without Comorbidities Predicts Cardiometabolic Diseases: Five-Year Japanese Cohort Study. Hypertension. 2017 06; 69(6):1036-1044.
Score: 0.017
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|